TY - JOUR
T1 - Severe acute malnutrition in childhood
T2 - Hormonal and metabolic status at presentation, response to treatment, and predictors of mortality
AU - Bartz, Sarah
AU - Mody, Aaloke
AU - Hornik, Christoph
AU - Bain, James
AU - Muehlbauer, Michael
AU - Kiyimba, Tonny
AU - Kiboneka, Elizabeth
AU - Stevens, Robert
AU - Bartlett, John
AU - St Peter, John V.
AU - Newgard, Christopher B.
AU - Freemark, Michael
PY - 2014/6
Y1 - 2014/6
N2 - Objective: Malnutrition is a major cause of childhood morbidity and mortality. To identify and target those at highest risk, there is a critical need to characterize biomarkers that predict complications prior to and during treatment. Methods: We used targeted and nontargeted metabolomic analysis to characterize changes in a broad array of hormones, cytokines, growth factors, and metabolites during treatment of severe childhood malnutrition. Children aged 6 months to 5 years were studied at presentation to Mulago Hospital and during inpatient therapy with milk-based formulas and outpatient supplementation with ready-to-use food.We assessed the relationship between baseline hormone and metabolite levels and subsequent mortality. Results: Seventy-seven patientswereenrolled in the study; a subsetwasfollowedupfrom inpatient treatment to the outpatient clinic. Inpatient and outpatient therapies increased weight/height z scores and induced striking changes in the levels of fatty acids, amino acids, acylcarnitines, inflammatory cytokines, and various hormones including leptin, insulin, GH, ghrelin, cortisol, IGF-I, glucagon- like peptide-1, and peptide YY.Atotal of 12.2% of the patients died during hospitalization; the major biochemical factor predicting mortality was a low level of leptin (P .0002), a marker of adipose tissue reserve and a critical modulator of immune function. Conclusions: We have used metabolomic analysis to provide a comprehensive hormonal and metabolic profile of severely malnourished children at presentation and during nutritional rehabilitation. Our findings suggest that fatty acid metabolism plays a central role in the adaptation to acute malnutritionandthatlowlevels of the adipose tissuehormoneleptin associate with,andmay predict, mortality prior to and during treatment.
AB - Objective: Malnutrition is a major cause of childhood morbidity and mortality. To identify and target those at highest risk, there is a critical need to characterize biomarkers that predict complications prior to and during treatment. Methods: We used targeted and nontargeted metabolomic analysis to characterize changes in a broad array of hormones, cytokines, growth factors, and metabolites during treatment of severe childhood malnutrition. Children aged 6 months to 5 years were studied at presentation to Mulago Hospital and during inpatient therapy with milk-based formulas and outpatient supplementation with ready-to-use food.We assessed the relationship between baseline hormone and metabolite levels and subsequent mortality. Results: Seventy-seven patientswereenrolled in the study; a subsetwasfollowedupfrom inpatient treatment to the outpatient clinic. Inpatient and outpatient therapies increased weight/height z scores and induced striking changes in the levels of fatty acids, amino acids, acylcarnitines, inflammatory cytokines, and various hormones including leptin, insulin, GH, ghrelin, cortisol, IGF-I, glucagon- like peptide-1, and peptide YY.Atotal of 12.2% of the patients died during hospitalization; the major biochemical factor predicting mortality was a low level of leptin (P .0002), a marker of adipose tissue reserve and a critical modulator of immune function. Conclusions: We have used metabolomic analysis to provide a comprehensive hormonal and metabolic profile of severely malnourished children at presentation and during nutritional rehabilitation. Our findings suggest that fatty acid metabolism plays a central role in the adaptation to acute malnutritionandthatlowlevels of the adipose tissuehormoneleptin associate with,andmay predict, mortality prior to and during treatment.
UR - http://www.scopus.com/inward/record.url?scp=84902334434&partnerID=8YFLogxK
U2 - 10.1210/jc.2013-4018
DO - 10.1210/jc.2013-4018
M3 - Article
C2 - 24606092
AN - SCOPUS:84902334434
SN - 0021-972X
VL - 99
SP - 2128
EP - 2137
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 6
ER -